Integrin β3-PKM2 pathway-mediated aerobic glycolysis contributes to mechanical ventilation-induced pulmonary fibrosis

Shuya Mei1, Qiaoyi Xu1, Yue Hu1

  • 1Department of Critical Care Medicine, Renji Hospital, School of Medicine, Shanghai Jiaotong University, 200127 Shanghai, China.

Theranostics
|September 28, 2022
PubMed

Insights

Mechanical ventilation (MV) can cause lung fibrosis by promoting aerobic glycolysis. Targeting the integrin β3-pyruvate kinase M2 (PKM2) pathway may offer a novel treatment for ventilator-induced lung injury.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Biochemistry

Background:

  • Mechanical ventilation (MV) is a life support measure that can paradoxically induce pulmonary fibrosis.
  • The precise mechanisms linking MV to lung fibrosis remain incompletely understood.

Purpose of the Study:

  • To investigate the role of aerobic glycolysis in MV-induced pulmonary fibrosis.
  • To elucidate the involvement of the integrin β3-pyruvate kinase M2 (PKM2) pathway in this process.

Main Methods:

  • Mice models with PKM2 or integrin β3 manipulation were subjected to mechanical ventilation.
  • Analysis included gene and protein expression, metabolomics, and cell-based assays.
  • Investigated collagen deposition, α-smooth muscle actin, and collagen I upregulation.

Main Results:

  • MV exposure led to increased collagen deposition and fibrosis markers in lung tissues.
  • Pulmonary fibroblasts showed elevated integrin expression and glycolysis.
  • The integrin β3-PKM2 pathway was upregulated in MV-induced lung fibrosis.
  • Inhibition of PKM2 or integrin β3 ameliorated MV-induced aerobic glycolysis and fibrosis.

Conclusions:

  • Aerobic glycolysis mediated by the integrin β3-PKM2 pathway is a key contributor to MV-induced pulmonary fibrosis.
  • Targeting this pathway offers a potential therapeutic strategy for ventilator-induced lung injury.

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
277
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
320